Physician profile
Susan O Sobel
NPI 1588908149
$4,511.40
in general payments reported to CMS, 2019-2025
25 companies · $925 in 2025
The $925 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $1,026 · 2023: $1,120 · 2024: $1,254 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,073 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,072.67 |
| Travel and Lodging | $225.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,127.29 | 2022-2023 | Intracept |
| Si-Bone, INC. | $639.04 | 2022-2024 | |
| Globus Medical, INC. | $463.18 | 2024-2025 | Senza, Modulus, Plymouth |
| Nevro Corp. | $458.44 | 2023-2024 | Senza |
| Abbott Laboratories | $362.72 | 2023-2024 | Eterna, Proclaim |
| Medtronic, INC. | $283.82 | 2023-2025 | Inceptiv, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Saluda Medical Americas, INC. | $140.22 | 2024 | Evoke |
| Davol INC. | $126.75 | 2024 | Arista Ah Flexitip |
| Horizon Therapeutics Plc | $124.77 | 2021 | |
| Abbvie INC. | $112.60 | 2025 | |
| Dynavax Technologies Corporation | $109.26 | 2022 | |
| Orthofix Medical, INC. | $95.20 | 2024 | Spinal-Stim |
| Spr Therapeutics, INC | $77.00 | 2024 | Sprint Pns System |
| Leo Pharma INC. | $63.45 | 2025 | Anzupgo |
| Collegium Pharmaceutical, INC. | $58.19 | 2024 | Belbuca |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $53.79 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Novartis Pharmaceuticals Corporation | $50.20 | 2025 | |
| Radius Health, INC. | $29.31 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $28.80 | 2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $21.16 | 2025 | |
| Endo Pharmaceuticals INC. | $20.73 | 2023 | Xiaflex |
| Organogenesis INC. | $17.93 | 2025 | Puraply Wound Matrix |
| Arcutis Biotherapeutics, INC. | $16.77 | 2025 | Zoryve |
| Forte Bio-Pharma LLC | $16.13 | 2024 | Prolate, Nalocet |
| Currax Pharmaceuticals LLC | $14.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Sobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.